Cardiac Insight, Inc.

Cardiac Insight, Inc. is a privately held medical device company based in Seattle, Washington, renowned for its Cardea SOLO ECG system. With FDA clearance since 2017, this tool provides comprehensive cardiac evaluations, comfortably worn over seven days. Dr. Dave Hadley and Dr. Vic Frolicher, creators of the Cardea 20/20 ECG, introduced a proprietary handheld 12-lead ECG device that enhances electrocardiogram reliability for detecting cardiovascular issues in young athletes, transforming athletic heart care. The Cardea 20/20 ECG incorporates breakthrough interpretive algorithms and international criteria, enabling swift identification of complex cardiac abnormalities leading to Sudden Cardiac Arrest (SCA). In 2021, Cardiac Insight joined forces with global electronic components leader Dreamtech, solidifying its position as a leading innovator in cardiac healthcare diagnostics, poised for exponential growth.